TAWNY SPURLOCK: Open Payments
NPI 1255808010 · POCATELLO, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 44 payments from 10 companies in 2025. Trend: 2023 $89 · 2024 $435 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $362 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $221 |
| Phathom Pharmaceuticals, Inc. | 6 | $160 |
| Regeneron Healthcare Solutions, Inc. | 5 | $103 |
| Janssen Biotech, Inc. | 2 | $96 |
| PFIZER INC. | 1 | $54 |
| Gilead Sciences, Inc. | 2 | $37 |
| TerSera Therapeutics LLC | 1 | $32 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: ENTYVIO, SKYRIZI, VOQUEZNA, RINVOQ, DUPIXENT, TREMFYA, VELSIPITY, Xermelo.
Industry payments across ID — which companies pay providers there.
